Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Moexipril for Primary Biliary Cirrhosis

This study has been completed.
Sponsor:
Collaborator:
UCB Pharma
Information provided by:
Mayo Clinic
ClinicalTrials.gov Identifier:
NCT00588302
First received: December 22, 2007
Last updated: May 20, 2011
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2007
  Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)